These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 1427455
1. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia. Velasco F, Torres A, Rojas R, Alvarez MA, Gomez P, Castillo D. Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455 [Abstract] [Full Text] [Related]
2. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura. Watanabe R, Wada H, Miura Y, Murata Y, Watanabe Y, Sakakura M, Okugawa Y, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Shiku H, Nobori T. Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985 [Abstract] [Full Text] [Related]
3. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices. Koyama T, Kakishita E, Nakai Y, Okamoto E. Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808 [Abstract] [Full Text] [Related]
4. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T. Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [Abstract] [Full Text] [Related]
5. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia. Cofrancesco E, Pogliani E, Salvatore M, Moreo G, Boschetti C, Cortellaro M. Acta Haematol; 1989 Jan; 81(3):122-5. PubMed ID: 2469277 [Abstract] [Full Text] [Related]
6. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia. Castaman G, Ruggeri M, Rodeghiero F. Thromb Res; 1989 Sep 01; 55(5):661-4. PubMed ID: 2814948 [No Abstract] [Full Text] [Related]
7. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. Chojnowski K, Wawrzyniak E, Treliński J, Niewiarowska J, Cierniewski C. Leuk Lymphoma; 1999 Dec 01; 36(1-2):77-84. PubMed ID: 10613452 [Abstract] [Full Text] [Related]
8. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation. Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi K, Shirakawa S, Hayashi T. Am J Hematol; 1993 Oct 01; 44(2):85-8. PubMed ID: 8266924 [Abstract] [Full Text] [Related]
9. [A new advance in theory of blood coagulation and fibrinolysis and its practical application]. Matsuno K, Araki K. Rinsho Byori; 1991 Feb 01; 39(2):179-84. PubMed ID: 1904112 [Abstract] [Full Text] [Related]
10. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Fukao H, Ueshima S, Okada K, Yamamoto K, Matsuo T, Matsuo O. Thromb Res; 1992 Oct 01; 68(1):57-65. PubMed ID: 1280377 [Abstract] [Full Text] [Related]
11. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M. Thromb Res; 2013 Jul 01; 132(1):e64-9. PubMed ID: 23726093 [Abstract] [Full Text] [Related]
12. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA. Br J Haematol; 1990 Apr 01; 74(4):471-9. PubMed ID: 2189490 [Abstract] [Full Text] [Related]
13. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis]. Uchida Y. Fukuoka Igaku Zasshi; 1991 Nov 01; 82(11):576-85. PubMed ID: 1774013 [Abstract] [Full Text] [Related]
14. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E. Rinsho Byori; 1991 Mar 01; 39(3):309-14. PubMed ID: 1828842 [Abstract] [Full Text] [Related]
15. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6. Kruithof EK, Mestries JC, Gascon MP, Ythier A. Thromb Haemost; 1997 May 01; 77(5):905-10. PubMed ID: 9184401 [Abstract] [Full Text] [Related]
16. Posttrauma coagulation and fibrinolysis. Gando S, Tedo I, Kubota M. Crit Care Med; 1992 May 01; 20(5):594-600. PubMed ID: 1533358 [Abstract] [Full Text] [Related]
17. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Watanabe R, Wada H, Watanabe Y, Sakakura M, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Nobori T, Shiku H. Thromb Res; 2001 Oct 01; 104(1):1-6. PubMed ID: 11583733 [Abstract] [Full Text] [Related]
18. A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia. Sureda A, García Frade LJ, Torrado MC, García Laraña J, García Avello A. Acta Haematol; 1992 Oct 01; 88(2-3):100-4. PubMed ID: 1281598 [Abstract] [Full Text] [Related]
19. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA. Garcia-Avello A, Garcia-Frade LJ, Gandarias C, Ocaña J, Cancelas JA, Lasso M. Thromb Res; 1994 Jan 15; 73(2):109-15. PubMed ID: 8171409 [Abstract] [Full Text] [Related]
20. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers]. Koike K, Fujimaki M. Nihon Rinsho; 1993 Jan 15; 51(1):37-42. PubMed ID: 8433526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]